We are dedicated to helping people suffering from neuropsychiatric disorders by transforming psychedelics into effective and licensed medicines.
Beckley Psytech’s innovative approach to helping patients in need is focused on developing novel psychedelic therapies to improve patient outcomes.
For our founders, Lady Amanda Feilding and Cosmo Feilding Mellen, psychedelic medicines have been a lifelong and intergenerational vocation.
We’re building a pipeline of differentiated psychedelic treatments for a variety of mental health and neurological disorders.
Get in touch to learn more about our work.